|
End-of-day quote
Other stock markets
|
||
| - GHS | - |
|
| Market Cap | 5.2M 60.74M 4.52M 4.21M 3.87M 7.3M 495M 7.43M 49.63M 19.46M 247M 19.51M 19.09M 817M | P/E 2017 |
11.7x | P/E 2018 | 6.9x |
|---|---|---|---|---|---|
| Enterprise Value | 10.45M 122M 9.08M 8.46M 7.78M 14.67M 996M 14.93M 99.77M 39.12M 496M 39.23M 38.37M 1.64B | EV / Sales 2017 |
1.34x | EV / Sales 2018 | 1.05x |
| Free-Float |
26.89% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 915K | |
| -2.39% | -6.24% | +47.10% | +146.73% | 1,024B | |
| -0.76% | -3.41% | +52.04% | +49.73% | 618B | |
| -2.33% | -5.50% | +25.55% | +64.08% | 443B | |
| +0.68% | +0.25% | +38.47% | +31.95% | 349B | |
| -1.66% | -1.89% | +32.18% | +37.17% | 297B | |
| -8.96% | -9.23% | +3.57% | +3.64% | 264B | |
| -1.37% | -5.71% | -2.10% | -44.43% | 209B | |
| -1.63% | +0.75% | +27.62% | +64.43% | 208B | |
| +0.72% | +1.42% | +15.88% | +73.30% | 162B | |
| Average | -0.98% | -1.35% | +26.70% | +47.40% | 357.38B | |
| Weighted average by Cap. | -0.69% | -2.17% | +34.56% | +69.56% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 8.89M 104M 7.73M 7.2M 6.62M 12.49M 848M 12.71M 84.93M 33.3M 423M 33.39M 32.66M 1.4B | 9.91M 116M 8.61M 8.02M 7.38M 13.92M 945M 14.16M 94.64M 37.11M 471M 37.21M 36.4M 1.56B |
| Net income | 665K 7.77M 578K 539K 495K 934K 63.4M 950K 6.35M 2.49M 31.61M 2.5M 2.44M 105M | 762K 8.9M 662K 617K 567K 1.07M 72.59M 1.09M 7.27M 2.85M 36.19M 2.86M 2.8M 120M |
| Net Debt | 4.15M 48.48M 3.6M 3.36M 3.09M 5.82M 395M 5.93M 39.61M 15.53M 197M 15.57M 15.23M 652M | 5.25M 61.37M 4.56M 4.25M 3.91M 7.37M 500M 7.5M 50.14M 19.66M 249M 19.71M 19.28M 825M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SPL Stock
Select your edition
All financial news and data tailored to specific country editions
